Evidence map›Paper›PMID 41176600›Full record

ArticleJournal of neuroinflammation2025

Inflammation associated microglial expansion disrupts hippocampal glial network communication, driving postoperative neurocognitive impairment.

Yuxiang Zheng, Wenjie Xu, Zizheng Suo, Yinyin Qu, Lina Lin, Enze Zhang, Dengyang Han, Meikui Wu, Hongyi Li, Hui Zheng and 2 more

Abstract read
In one paragraph

Article in Journal of neuroinflammation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yuxiang ZhengDepartment of Anesthesiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Wenjie XuDepartment of Anesthesiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Zizheng SuoDepartment of Anesthesiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Yinyin QuDepartment of Anesthesiology, Peking University Third Hospital, Beijing, 100191, China.
Lina LinDepartment of Anesthesiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Enze ZhangDepartment of Anesthesiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Dengyang HanDepartment of Anesthesiology, Peking University Third Hospital, Beijing, 100191, China.
Meikui WuDepartment of Anesthesiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Hongyi LiDepartment of Anesthesiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Hui ZhengDepartment of Anesthesiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Ting XiaoState Key Laboratory of Molecular Oncology, Department of Etiology and Carcinogenesis, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China. xiaot@cicams.ac.cn.
Cheng NiDepartment of Anesthesiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China. nicheng@cicams.ac.cn.

Funding

Beijing Natural Science Foundation 7232131CAMS Innovation Fund for Medical Sciences 2025-12M-C&T-B-044National High Level Hospital Clinical Research Funding 80102022519National Key R&D Program of China 2022YFF0705004National Natural Science Foundation of China 82171195Nonprofit Central Research Institute Fund of Chinese Academy of Medical Sciences 2023-JKCS-25Talent Project of National Cancer Center/Cancer Hospital Chinese Academy of Medical Sciences For Dr. Cheng Ni
6 · The paper itself

Abstract

backgroundPostoperative neurocognitive impairment (PNCI) significantly affects the recovery and long-term outcomes of elderly patients, with central nervous system (CNS) inflammation serving as the key pathogenic driver of its development. As the resident immune cells of the CNS, microglia play a crucial role in regulating perioperative inflammation and maintaining homeostasis. However, the contribution, phenotypic heterogeneity, and communication network of perioperative microglia in the development of PNCI remain insufficiently characterized.

methods18-month-old mice underwent surgery and developed PNCI. The hippocampi of mice in both control and surgery groups were dissected 24 h postoperatively for single-cell RNA sequencing. Immunofluorescence coupled with fluorescence in situ hybridization was used to verify the number of subpopulations and the expression levels of target RNA transcripts in the hippocampus. Cognitive function tests were conducted to evaluate the effects of the TNF inhibitor etanercept in PNCI model.

resultsEight microglial subpopulations and six astrocytic subpopulations were identified in the hippocampus. Postoperatively, the percentage of microglial subpopulations underwent dramatic changes, with inflammation associated microglia (IAM) increasing more than 14-fold and transition state microglia (TSM) increasing more than 33-fold. These alterations were accompanied by a marked enhancement of intercellular communications among glial cells, particularly driven by the activation of TNF signaling pathway in IAM. This pathway, along with its associated regulatory network, critically modulated the function of astrocytes and endothelial cells, thereby playing a pivotal role in CNS inflammation and the subsequent development of PNCI. Notably, administration of TNF inhibitor etanercept attenuated IAM activation and glial network communication in the hippocampus, which was associated with improved cognitive performance in PNCI mice.

conclusionThese results highlight the pivotal role of TNF signaling activation in IAM and its associated glial cell communication as the fundamental mechanism driving hippocampal CNS inflammation, which subsequently contributes to the onset and progression of PNCI.

Indexed as

Cell CommunicationHippocampusInflammationMicrogliaNeurogliaPostoperative Cognitive ComplicationsAnimalsMaleMiceMice, Inbred C57BLGlial network communicationInflammation associated microgliaPostoperative neurocognitive impairmentSingle cell RNA sequencingTumor necrosis factor

Identifiers

PMID41176600
PMCPMC12579419

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.